Cellectar Biosciences, Inc. (CLRB) earnings
CLRB earnings moved a median of -0.60% by the close. Quarterly and annual CLRB reports and results, each read against the price at its own news timestamp. Back to the CLRB overview →
26 measured CLRB earnings events.
Where these CLRB earnings landedvs 24 measured CLRB earnings reactions
| Middle 50% of CLRB earnings reactions | -4.52% to +3.31% |
|---|---|
| Median reaction (to close) | -0.60% |
| Measured reactions | 24 |
Point-in-time · zero look-ahead
Half of the 24 CLRB earnings events with a measured close landed between -4.52% and +3.31%; 46% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Cellectar Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates | Press release | +2.99% | -1.20% | |
| Form 10-Q Cellectar Biosciences, For: Jun 30 | SEC filing · Form 10-Q | +2.99% | -1.20% | |
| Cellectar Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates | Press release | +2.88% | +15.11% | |
| Form 10-Q Cellectar Biosciences, For: Mar 31 | SEC filing · Form 10-Q | +2.88% | +15.11% | |
| Form 10-K/A Cellectar Biosciences, For: Dec 31 | SEC filing · Form 10-K | +1.51% | +1.51% | |
| Form 10-K Cellectar Biosciences, For: Dec 31 | SEC filing · Form 10-K | +5.74% | +3.94% | |
| Cellectar Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update | Press release | -7.76% | — | |
| Form 10-Q Cellectar Biosciences, For: Sep 30 | SEC filing · Form 10-Q | -7.76% | — | |
| Cellectar Biosciences Reports Second Quarter 2025 Financial Results and Provides a Corporate Update | Press release | +2.13% | -5.96% | |
| Form 10-Q Cellectar Biosciences, For: Jun 30 | SEC filing · Form 10-Q | +2.13% | -5.96% | |
| Cellectar Biosciences Reports First Quarter 2025 Financial Results and Provides a Corporate Update | Press release | -0.49% | -10.35% | |
| Form 10-Q Cellectar Biosciences, For: Mar 31 | SEC filing · Form 10-Q | -0.49% | -10.35% | |
| Form 10-K Cellectar Biosciences, For: Dec 31 | SEC filing · Form 10-K | -3.00% | -6.26% | |
| Form 10-Q Cellectar Biosciences, For: Sep 30 | SEC filing · Form 10-Q | +2.43% | -4.32% | |
| Form NT 10-Q Cellectar Biosciences, For: Sep 30 | SEC filing · Form NT | +0.24% | -3.83% | |
| Cellectar Biosciences Announces Compliance Regarding Filing of Form 10-Q | Press release | +0.00% | +0.00% | |
| Form 10-K/A Cellectar Biosciences, For: Dec 31 | SEC filing · Form 10-K | +3.85% | +0.49% | |
| Form 10-Q Cellectar Biosciences, For: Jun 30 | SEC filing · Form 10-Q | +3.85% | +0.49% | |
| Form 10-Q/A Cellectar Biosciences, For: Mar 31 | SEC filing · Form 10-Q | +3.85% | +0.49% | |
| Form NT 10-Q Cellectar Biosciences, For: Jun 30 | SEC filing · Form NT | +0.51% | +4.10% | |
| Form 10-Q Cellectar Biosciences, For: Mar 31 | SEC filing · Form 10-Q | +4.17% | +6.00% | |
| Form 10-K/A Cellectar Biosciences, For: Dec 31 | SEC filing · Form 10-K | -1.81% | +3.10% | |
| Form 10-K Cellectar Biosciences, For: Dec 31 | SEC filing · Form 10-K | -4.57% | -5.09% | |
| Cellectar Biosciences to Announce 2023 Year End Earnings Results and Host a Conference Call on Wednesday, March 27, 2024 | Press release | -2.90% | -1.84% | |
| Form 10-Q Cellectar Biosciences, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +6.70% | |
| Cellectar Biosciences to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 2, 2023 | Press release | -2.65% | -3.79% |
Keep exploring
More CLRB: analyst actions → · SEC filings → · CLRB overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Qiagen N.V. Common Shares (QGEN) | 266 | +0.05% | 53% |
| 22nd Century Group, Inc (XXII) | 266 | -1.87% | 30% |
| EVOTEC AG S/ADR (EVTCY) | 265 | 0.00% | 17% |
| MiMedx Group, Inc (MDXG) | 265 | +0.14% | 57% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.